A biotechnology business called Insempra, situated near Munich, Germany, has raised $20 million.
Investors
- Alante Capital
- Taavet Sten
- Acequia Capital
- Henkel dx Ventures
- Bayern Kapital
- EQT Ventures
- BlueYard Capital
- Possible Ventures
Use of funds
The business plans to use the money to support the expansion of its technology research, development, and production capabilities as well as to carry on developing a technological platform that supplies high-performance, inherently sustainable ingredients for a variety of sectors.
About Insempra
Under the direction of CEO and Founder Jens Klein, Insempra is a biotechnology-driven firm that empowers companies in the food & nutrition, fashion, and beauty & personal care sectors to revolutionize their ingredient lists by introducing goods that are created in partnership with nature.
Lipids are now being grown by Insempra for use in food and cosmetic products. It is also advancing its biological solutions to manufacture new natural chemicals for usage in functional substances like antioxidants, preservatives, flavors, and scents. This technology offers a bio-based substitute for common materials like polymers and textiles.
“We are grateful for the support of this group of investors who have recognized the potential of Insempra’s market-first approach and innovative technology platform. We will continue to increase our ability to create superior-quality, fundamentally sustainable materials through cooperation with nature, which will lessen our reliance on chemical industrialization methods.”
Jens Klein
